| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/29/2014 | US8710193 Antibody recognizing turn structure in amyloid β |
| 04/29/2014 | US8710192 PCSK9 antagonists |
| 04/29/2014 | US8710009 HSP20 inhibits amyloidogenesis and neurotoxicity |
| 04/29/2014 | US8710004 Stable liquid VEGF antagonist formulations |
| 04/29/2014 | US8709995 Method for eliciting an immune response to human telomerase reverse transcriptase |
| 04/29/2014 | US8709813 DNA promoters and anthrax vaccines |
| 04/29/2014 | US8709799 Lentiviral gene transfer vectors and their medicinal applications |
| 04/29/2014 | US8709780 Method for producing purified influenza virus antigen |
| 04/29/2014 | US8709778 Method of adenoviral vector synthesis |
| 04/29/2014 | US8709730 Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins |
| 04/29/2014 | US8709447 Compositions and methods for activating innate and allergic immunity |
| 04/29/2014 | US8709446 HYR1 as a target for active and passive immunization against Candida |
| 04/29/2014 | US8709445 Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists |
| 04/29/2014 | US8709444 Live-attenuated compositions for bacterial infections |
| 04/29/2014 | US8709443 Reovirus for the treatment of cellular proliferative disorders |
| 04/29/2014 | US8709442 Recombinant negative strand virus RNA expression systems and vaccines |
| 04/29/2014 | US8709441 TC-83-derived alphavirus vectors, particles and methods |
| 04/29/2014 | US8709438 Vaccine composition against Streptococcus pyogenes |
| 04/29/2014 | US8709437 Clostridium chauvoei polypeptide, DNA encoding the polypeptide and a vaccine comprising the polypeptide |
| 04/29/2014 | US8709436 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 04/29/2014 | US8709435 Hypallergenic mosaic antigens and methods of making same |
| 04/29/2014 | US8709434 Compositions for inhibiting NADPH oxidase activity |
| 04/29/2014 | US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 04/29/2014 | US8709430 Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids |
| 04/29/2014 | US8709429 Markers of acute myeloid leukemia stem cells |
| 04/29/2014 | US8709428 Antibodies to Clostridium difficile toxins |
| 04/29/2014 | US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709425 Antibodies to non-functional P2X7 receptor |
| 04/29/2014 | US8709424 Anti-GITR antibodies |
| 04/29/2014 | US8709422 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 04/29/2014 | US8709421 Combination of the application of antibodies for immunostimulation together with glucocorticoids |
| 04/29/2014 | US8709419 Combination therapy |
| 04/29/2014 | US8709418 Pharmaceutical composition for treating CAPRIN-1 expressing cancer |
| 04/29/2014 | US8709417 Combination immunotherapy for the treatment of cancer |
| 04/29/2014 | US8709416 Compositions of PD-1 antagonists and methods of use |
| 04/29/2014 | US8709415 Antibodies to OX-2/CD200 and uses thereof |
| 04/29/2014 | US8709414 Superagonistic anti-CD28 antibodies |
| 04/29/2014 | US8709413 Treatment of celiac disease with IgA |
| 04/29/2014 | US8709412 Modulation of TIM receptor activity in combination with cytoreductive therapy |
| 04/29/2014 | US8709411 Combination therapy to enhance NK cell mediated cytotoxicity |
| 04/29/2014 | US8709410 Anti-prion protein antibody fragment |
| 04/29/2014 | US8709409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate |
| 04/29/2014 | US8709405 Cancer vaccines containing epitopes of oncofetal antigen |
| 04/29/2014 | US8709398 Probiotic Bifidobacterium strains |
| 04/29/2014 | US8709397 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 04/29/2014 | CA2789115C Microporation of tissue for delivery of bioactive agents |
| 04/29/2014 | CA2631931C Cancer therapies and pharmaceutical compositions used therein |
| 04/29/2014 | CA2542668C A method for increasing cd8+ cytotoxic t cell reponses and for treating multiple sclerosis |
| 04/29/2014 | CA2534907C Homogeneous preparations of il-28 and il-29 |
| 04/29/2014 | CA2493124C Vaccine |
| 04/29/2014 | CA2462946C Recombinant p. falciparum merozoite protein-142 vaccine |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/29/2014 | CA2232048C Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 04/24/2014 | WO2014063155A1 Thy1 (cd90) as a novel therapy to control adipose tissue accumulation |
| 04/24/2014 | WO2014063134A1 Methods for inhibiting osteolysis |
| 04/24/2014 | WO2014062845A1 Compositions and methods for detecting sessile serrated adenomas/polyps |
| 04/24/2014 | WO2014062778A1 Methods and compositions for the treatment of cancer |
| 04/24/2014 | WO2014062659A2 Methods of treating ocular diseases |
| 04/24/2014 | WO2014062621A1 Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits |
| 04/24/2014 | WO2014062580A1 Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens |
| 04/24/2014 | WO2014061914A1 Infectious bronchitis virus k40/09 strain, and vaccine for infectious bronchitis using same |
| 04/24/2014 | WO2014061783A1 Human antibody specific to toxin produced from clostridium difficile, or antigen-binding fragment thereof |
| 04/24/2014 | WO2014061277A1 Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| 04/24/2014 | WO2014060905A1 Recombinant novirhabdovirus usable as an antigen vector |
| 04/24/2014 | WO2014060712A1 Immunomodulatory proteins |
| 04/24/2014 | WO2014060389A2 Immunogenic composition |
| 04/24/2014 | WO2014060385A1 Immunogenic composition |
| 04/24/2014 | WO2014060383A1 Immunogenic composition comprising 1 or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila fromhaemophilus influenzae. |
| 04/24/2014 | WO2014060210A1 Methods and compositions for the treatment of pancreatic cancer |
| 04/24/2014 | WO2014060049A1 Compositions for immunotherapy |
| 04/24/2014 | WO2014059489A1 Improved human herpesvirus immunotherapy |
| 04/24/2014 | WO2014043403A4 Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase |
| 04/24/2014 | WO2014040025A3 Immunogens of hiv-1 broadly neutralizing antibodies, methods of generation and uses thereof |
| 04/24/2014 | WO2014033158A3 Pcsk9 peptide vaccine |
| 04/24/2014 | WO2014031429A3 Liposome formulations |
| 04/24/2014 | WO2013192550A3 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof |
| 04/24/2014 | WO2013029033A3 Rotavirus preparations with excess calcium ions and high viscosities that ensure vaccine viability at elevated temperatures |
| 04/24/2014 | WO2012115903A3 Yeast strain for the production of proteins with modified o-glycosylation |
| 04/24/2014 | WO2012112690A3 Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
| 04/24/2014 | WO2012096975A3 Method of predicting responsiveness of b cell lineage malignancies to active immunotherapy |
| 04/24/2014 | US20140115727 NOVEL ANTI-cMET ANTIBODY |
| 04/24/2014 | US20140113371 Cryopreservation of Haptenized Tumor Cells |
| 04/24/2014 | US20140112979 Methods for producing liposomes |
| 04/24/2014 | US20140112977 Allogeneic autophagosome-enriched composition for the treatment of disease |
| 04/24/2014 | US20140112954 Method for preparing hbv vaccine comprising aluminum adjuvant |
| 04/24/2014 | US20140112953 Inactivated dengue virus vaccine |
| 04/24/2014 | US20140112952 Attenuated polioviruses |
| 04/24/2014 | US20140112951 Vaccine and drug delivery by topical application of vectors and vector extracts |
| 04/24/2014 | US20140112950 Combination vaccines with lower doses of antigen and/or adjuvant |
| 04/24/2014 | US20140112944 Compositions and methods for treating cancer |
| 04/24/2014 | US20140112943 Method of developing a vaccine using peptide-poly ic complexes |
| 04/24/2014 | US20140112942 Agonistic antibody to cd27 |
| 04/24/2014 | US20140112941 Mammalian receptors as targets for antibody and active vaccination therapy against mold infections |
| 04/24/2014 | US20140112939 Methods for Inhibiting Osteolysis |
| 04/24/2014 | US20140112938 Composition and method for the treatment and prevention of enteric bacterial infections |
| 04/24/2014 | US20140112937 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists |
| 04/24/2014 | US20140112936 Methods of neutralizing viral infection |
| 04/24/2014 | US20140112935 Antibodies to interleukin-6 and use thereof |
| 04/24/2014 | US20140112934 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |